We are specialized in the development and production of IVD reagents for the most advanced Clinical Chemistry and Molecular Biology platforms and we are between the most important players operating in the sector of colorectal cancer screening and prevention.
We believe in Research, in Quality and in the continuous improvement of our diagnostic tests. Thanks to these values and the long-lasting fruitful partnerships with prestigious companies, our brand is well known and appreciated on a worldwide scale.
Are you interested in our world?
Have a look at our website and get to know us better.
Overview
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 4, 2021 | Sentinel Diagnostics Launches Two New Serological Tests To Quickly Assess The Immunoresponse To SARS-CoV-2 USA - English USA - English USA - English | |
| May 4, 2021 | Sentinel Diagnostics Launches Two New Serological Tests To Quickly Assess The Immunoresponse To SARS-CoV-2 | MILAN, May 4, 2021 /PRNewswire/ -- To quickly assess the immune response to SARS-CoV-2 of patients and entire communities, Sentinel Diagnostics - an Italian company focused for more than 35 years on the development and production of In Vitr... |
Reviews 0
FAQ about Sentinel Diagnostics
When was Sentinel Diagnostics founded?
Sentinel Diagnostics was founded in 1983.
What has the press written about Sentinel Diagnostics?
Parsers VC has collected 3 articles mentioning Sentinel Diagnostics, among them “Sentinel Diagnostics Launches Two New Serological Tests To Quickly Assess The Immunoresponse To SARS-CoV-2 USA - English USA - English USA - English” (May 4, 2021) and “Sentinel Diagnostics Launches Two New Serological Tests To Quickly Assess The Immunoresponse To SARS-CoV-2” (May 4, 2021).
Is Sentinel Diagnostics still active?
Yes, Sentinel Diagnostics is active; its latest activity on Parsers VC dates from Nov 14, 2022.